Abstract:4343 Many cancer cells exhibit mitochondrial respiratory dysfunction due to multiple factors including mitochondrial DNA (mtDNA) mutations, hypoxia in tumor tissues, and oncogenic signals. An important consequence of mitochondrial respiration defect in cancer cells is a decrease of ATP generation in the mitochondria and an increase of aerobic glycolysis in the cytosol (the Warburg effect). However, the precise relationship between mitochondrial dysfunction and cancer cell survival remain elusive, and the potential therapeutic implications remain to be investigated. To study underlying mechanisms and test new therapeutic approaches, a novel model system harboring a dominant negative form of mitochondrial DNA polymerase gamma (POLGdn) was expressed in the T-ReX293 tetracycline inducible cell system (tet/on system). Mitochondrial dysfunctions, including a significant decrease in mtDNA content, mtDNA-encoded RNA/protein expression, and oxygen consumption, were observed upon POLGdn expression (tet/on). Increased glycolysis was also observed, as evidenced by elevated glucose uptake, lactate production, and HKII protein expression. Importantly, NOX activation was observed in this model system two days after POLGdn expression. Detail analysis revealed an increased expression of NOXA1 and p47, associated with an increase in NOX activity and increased ROS generation compared with the non-induced (tet/off) cells. Upon treatment of the cells with DPI, a NOX inhibitor, tet/on cells exhibited a decrease in glucose uptake and ATP level, but showed a slight increase in lactate production. In contrast, the tet/off cells showed no change in glucose uptake and ATP level but had a significant increase in lactate production. Tet/on cells showed resistance to gemcitabine and taxol treatment, but sensitive to DPI treatment. Further analysis by comparing immortalized ovarian epithelial T72 cells with the Ras transformed tumorigenic T72-Ras cells showed that the transformed cells had increased NOX activity, increased gene expression of NOX1, NOX2 and p47, and more sensitive to DPI treatment especially under hypoxic condition while mitochondrial respiration was suppressed. These data together suggest that mitochondrial dysfunction leads to NOX activation, and that NOX inhibition might have potential implications in cancer therapeutics.

A mitotic NADPH upsurge promotes chromosome segregation and tumour progression in aneuploid cancer cells

Modulation of G6PD Affects Bladder Cancer Via ROS Accumulation and the AKT Pathway in Vitro.

O-GlcNAcylation of G6PD Promotes the Pentose Phosphate Pathway and Tumor Growth

Mitochondrial Redox Signaling And Tumor Progression

Nucleophosmin Regulates Intracellular Oxidative Stress Homeostasis via Antioxidant PRDX6

Nicotinamide Nucleotide Transhydrogenase-Mediated Redox Homeostasis Promotes Tumor Growth and Metastasis in Gastric Cancer

Disrupting G6PD-mediated Redox Homeostasis Enhances Chemosensitivity in Colorectal Cancer

Disrupted Mitochondrial Homeostasis Coupled with Mitotic Arrest Generates Antineoplastic Oxidative Stress.

MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions

Cytosolic malic enzyme and glucose‐6‐phosphate dehydrogenase modulate redox balance in NSCLC with acquired drug resistance

A GSTP1-mediated lactic acid signaling promotes tumorigenesis through the PPP oxidative branch

Increased nicotinamide adenine dinucleotide pool promotes colon cancer progression by suppressing reactive oxygen species level

Targeting Glucose-6-phosphate Dehydrogenase by 6-AN Induces ROS-mediated Autophagic Cell Death in Breast Cancer

Energy Restriction Causes Metaphase Delay and Chromosome Mis-Segregation in Cancer Cells.

NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism

Targeting NAD+ Metabolism: Dual Roles in Cancer Treatment

Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer

Mitochondrial Dysfunction Leads to NADPH Oxidase (NOX) Activation and Sensitization of Cancer Cells to NOX Inhibitor

Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition

The 8-oxoguanine DNA glycosylase-synaptotagmin 7 pathway increases extracellular vesicle release and promotes tumour metastasis during oxidative stress

Chromosomal instability-induced senescence potentiates cell non-autonomous tumourigenic effects